CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 4,900 shares, a decrease of 98.9% from the October 31st total of 429,500 shares. Based on an average daily volume of 40,600 shares, the days-to-cover ratio is currently 0.1 days.
CSPC Pharmaceutical Group Stock Performance
CSPCY traded up C$0.08 on Thursday, hitting C$2.64. 5,526 shares of the company were exchanged, compared to its average volume of 40,428. The stock’s fifty day moving average is C$2.93 and its 200-day moving average is C$2.97. CSPC Pharmaceutical Group has a 12 month low of C$2.25 and a 12 month high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The company also recently announced a dividend, which will be paid on Thursday, December 5th. Investors of record on Friday, November 1st will be paid a $0.0575 dividend. The ex-dividend date of this dividend is Friday, November 1st. This is a boost from CSPC Pharmaceutical Group’s previous dividend of $0.06.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Recommended Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Utilities Stocks Explained – How and Why to Invest in Utilities
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Where Do I Find 52-Week Highs and Lows?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.